| MCO |
Report |
Adjusted Diluted EPS (Q2'26) |
BEAT |
pred ~$4.32 vs. cons $4.23 |
MEDIUM |
| MCO |
Report |
MIS Revenue Growth y/y (Q2'26) |
BEAT |
pred ~+14% vs. cons ~+11% |
MEDIUM |
| MCO |
Report |
MA ARR Growth y/y (Q2'26) |
BEAT |
pred ~+9% vs. cons ~+8.5% |
MEDIUM |
| MCO |
Guide |
FY26 Adjusted Diluted EPS guidance |
BETTER |
guide ~$16.75-$17.25 (mid ~$17.00) vs. cons ~$16.75 (FY2026) |
MEDIUM |
| MCO |
Guide |
FY26 MIS Revenue Growth guidance |
BETTER |
guide ~+9-10% vs. cons ~+8% (FY2026) |
MEDIUM |
| MCO |
Guide |
FY26 MA Adjusted Operating Margin guidance |
UNCHANGED |
guide ~34-35% vs. cons ~34.5% (FY2026) |
MEDIUM |
| MCO |
Guide |
FY26 Share Repurchase guidance |
UNCHANGED |
guide ~$2.5B vs. cons ~$2.5B (FY2026) |
HIGH |
| MCO |
Return |
Day-1 residual (stock − beta × S&P 500) |
+3.0% |
— |
MEDIUM |
| MCO |
Return |
5-day cumulative residual |
+1.0% (FADE) |
A likely beat-and-reaffirm/modest-raise triggers an initial relief pop off the stock's -5.5% pre-print pullback from its $519 high, but the setup (37x trailing earnings, H1 already front-loaded via low-double-digit MIS growth per management's own framing) implies tougher H2 comps; any full-year raise will likely be smaller than the magnitude of the H1 beat, so sell-side models trim implicit H2/out-quarter MIS growth and MA revenue (divestiture drag) even as headline EPS clears the bar, causing profit-taking and partial fade of the initial pop over the following days. |
MEDIUM |